in this episode, we dive deep into the world of oncology and explore the crucial topic of endpoints beyond overall survival (OS) and their pivotal role in health technology assessment (HTA). our guest, bob bick will provide background on how these alternative endpoints are reshaping the landscape of cancer research, and how this will impact health technology assessment. we'll examine the far-reaching implications of this paradigm shift. don't miss this insightful conversation that sheds light on the evolving standards of cancer care.